Last but not least, it was shown that T-VEC therapy has both direct and indirect anti-tumor properties this approach causes tumor cell death at the same time as the release of ICD hallmark mediators and simultaneously promotes the maturation of BDCA-1+ myDCs (132). This evidence concerns the gene CD1C and neoplasm.